Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R9FM
|
|||
| Former ID |
DIB002629
|
|||
| Drug Name |
SentoClone
|
|||
| Synonyms |
Autologous T lymphocyte therapy (malignant melanoma), SentoClone; Autologous Th1 cell therapy (malignant melanoma), SentoClone
Click to Show/Hide
|
|||
| Indication | Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 2 | [1] | |
| Company |
Sentoclone Therapeutics Ab
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00991250) SentoClone Compared to Reference Treatment in Advanced Malignant Melanoma. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.